AIM News and Press, AIM ImmunoTech Inc. From 01/06/21

OCALA, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the active AMP-511 Expanded Access Program (EAP) has dosed its first COVID-19 “Long Hauler” patient with the drug Ampligen (rintatolimod), marking a significant mil...

Note: This was a holiday-shortened roundtable this week. Next week's episode will follow a similar format and be aired around the same time. Stocks closed higher going into the holidays thanks to late buying due in large part to the Brexit deal in Brussels. The week started with “risk-...

4 Hot Penny Stocks To Buy? Some Traders Think So Penny stocks are some of the most volatile asset classes in the stock market today. Whether you want to talk about speculative momentum or simple price action, these cheap stocks are built for both. For one, the companies behind the s...

OCALA, Fla., Dec. 24, 2020 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announced today that the post-COVID-19 “Long Hauler” portion of the active AMP-511 Expanded Access Program (EAP) protocol received approval from the Institutional Review Board (IRB) for...

AIM ImmunoTech (AIM) gains 13% in premarket after Institutional Review Board's ((IRB)) green signal to commence enrollment in post-COVID-19 "Long Hauler" portion of the active AMP-511 Expanded Access Program, evaluating Ampligen.The program is authorized to enroll up to 100 act...

SIFCO Industries (SIF) +54% on Q4 results.Creative Realities (CREX) +21%.Triterras (TRIT) +19%.AIM ImmunoTech (AIM) +17%.Bridgetown Holdings Limited (BTWN) +16%.Lightbridge Corporation (LTBR) +24% after nabbing patent in Eurasia for nuclear fuel assemblies.IZEA Worldwide (IZEA) +15%...

AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 ‘Long Haulers' Institutional Review Board Authorizes Public Notification for Potential Enrollment of Subjects OCALA, FL / ACCESSWIRE / December 24, 2020 / AIM Imm...

HEXO (HEXO) -74% Soligenix SNGX -51% as SGX942 flunks oral mucositis study in cancer patients.Forward Industries (FORD) -15%.Venus Concept VERO -16% on announcing public offering.Exicure XCUR -14% on announcing issuance of two new U.S. patents, and new ...

4 Biotech Penny Stocks To Watch Right Now No matter how you slice it, COVID-19 has helped certain penny stocks just as much as it’s hurt small-cap companies. While things like travel and physical retail were hit hard, other things like digital tech and biotechnology/health ca...

EyeGate Pharmaceuticals (EYEG) +87% as it acquires Panoptes Pharma.NantKwest (NK) +32% as its partner, ImmunityBio, achieves primary endpoint in bladder cancer study.RealPage (RP) +31% as Thoma Bravo has agreed to buy the company for $9.6B.China Customer Relations Centers (CCRC...